Novel excipients are quickly important to overcome formulation challenges in advanced drug distribution systems. Despite regulatory obstacles and unclear definitions, their role is expanded in improving stability, solubility and bioavailability. This article examines the most important application ...

Pharmaceutical CDMOs are quickly exposed to cybersecurity risk and complex compliance requirements, which they manage in the global network due to sensitive data. Problems such as third-party weaknesses and limited adoption of zero-trust framework combine to create a challenge. This article highlig...

Pharmaceutical companies increasingly concentrate on sterile fill-finish services because they must respond to both higher biologics requirements and advancing medical therapies and changing patient needs. The pharmaceutical industry evolves through advancements in sterile production methods along ...

Drug supply chains are facing increasing risks from geopolitical and environmental disorders. CDMO plays an important role in ensuring medical supply stability by using flexible strategies. As the industry develops, small-molecule CDMOs should embrace innovation and agility to balance supply and de...